NRX Pharmaceuticals, Inc.

NRXP · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.1B · 29 employees
213
SEC Filings
$3.37
Close 2026-09-09
29
Employees

Business Summary

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) is a clinical-stage biopharmaceutical company developing novel therapeutics for central nervous system disorders including suicidal depression, PTSD, chronic pain, and schizophrenia. Its lead candidates are KETAFREE (preservative-free generic ketamine), NRX-100 (IV ketamine formulation), and NRX-101 (oral fixed-dose D-cycloserine/lurasidone combination). Through majority-owned subsidiary HOPE Therapeutics, Inc., the company operates interventional psychiatry clinics in Florida offering ketamine infusion, TMS, Spravato, hyperbaric therapy, and digital therapeutics.

Latest Stock Quote

NRXP 2026-09-09 $3.37 O:$3.48 H:$3.52 L:$3.34 Vol:0.5M VWAP:$3.4139
origin leaf: null

Next Earnings

expected 2026-12-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001437749-26-009418EDGAR96K words
2025-03-142024-12-310001437749-25-007743EDGAR97K words
2024-03-292023-12-310001558370-24-004396EDGAR95K words
2023-03-312022-12-310001558370-23-005292EDGAR—
2022-03-312021-12-310001558370-22-004899EDGAR—
2021-04-012020-12-310001654954-21-003783EDGAR—
2020-03-302019-12-310001654954-20-003527EDGAR—
2019-03-152018-12-310001654954-19-002833EDGAR—
2018-03-232017-12-310001654954-18-003022EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001437749-26-028027EDGAR38K words
2025-11-142025-09-300001437749-25-035210EDGAR48K words
2025-08-182025-06-300001437749-25-027167EDGAR35K words
2025-05-152025-03-310001437749-25-017252EDGAR32K words
2024-11-142024-09-300001437749-24-035289EDGAR35K words
2024-08-142024-06-300001437749-24-026847EDGAR30K words
2024-05-142024-03-310001558370-24-008144EDGAR31K words
2023-11-142023-09-300001558370-23-019008EDGAR33K words
2023-08-142023-06-300001558370-23-014873EDGAR29K words
2023-05-152023-03-310001558370-23-009950EDGAR20K words
2022-11-142022-09-300001558370-22-017772EDGAR—
2022-08-152022-06-300001558370-22-013673EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-160001437749-26-030492EDGAR1K words
2026-09-140001437749-26-030228EDGAR1K words
2026-08-170001437749-26-028111EDGAR1K words
2026-08-070001437749-26-026428EDGAR1K words
2026-07-220001437749-26-024037EDGAR1K words
2026-03-240001437749-26-009611EDGAR1K words
2026-02-170001437749-26-004246EDGAR1K words
2026-02-170001437749-26-004245EDGAR1K words
2026-02-020001437749-26-002682EDGAR1K words
2026-01-160001437749-26-001455EDGAR2K words

213 total filings indexed. 182 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

central-nervous-system-disorders suicidal-depression-treatment bipolar-depression-treatment post-traumatic-stress-disorder-(ptsd) schizophrenia-treatment chronic-pain-treatment interventional-psychiatry-services generic-ketamine-market n-methyl-d-aspartate-(nmda)-receptor-modulation transcranial-magnetic-stimulation-(tms) real-world-evidence-(rwe)-per-fda-2025-guidance one-d-protocol-(one-day-tms-with-d-cycloserine) focused-tms-with-neuro-navigation-guided-by-brain-imaging hyperbaric-therapy digital-therapeutics

Company Identity

CIK0001719406
TickerNRXP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://nrxpharma.com
Listed2021-05-25

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 97238a538f83842379e6259bea1d59cb7d4449e03db479780d6715892186cc81
parent: 6ae917890881ce16af328f01b7e13c2f6f3eb6b10a8436faf8057d4f09c6b2b3
content hash: 91dc8db2104092cbd82f43c3a6cdf198392d72ed1b46df291a2fe3f4070d6919
signed: 2026-09-28T19:02:25.073Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up NRXP using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on NRXP, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/NRXP (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.